Funding of £5m will create new jobs in Norfolk

Published: 28-Jan-2010
Manufacturing Research & Development Finance Pharmaceutical

Thirty new laboratories and offices for 300 research scientists are to be built in Norfolk, UK

Thirty new laboratories and offices for 300 research scientists are to be built in Norfolk, UK with £5m of funding from a partnership including the Biotechnology and Biological Sciences Research Council (BBSRC).

The new development will be based at Norwich Science Park and provide facilities for start-up and expanding businesses.

BBSRC will provide £500,000 as well as the land and buildings to host the new facilities, with £1.4m coming from the East of England Development Agency (EEDA), £1m from the Greater Norwich Development Partnership (GNDP), £500,000 from NRP partner the University of East Anglia (UEA), and the remainder from other NRP partners.

The new facilities, to be opened in July, will be managed by a new joint venture company called Colney Innovations (CIL).

David Parfrey, BBSRC director of finance and director of CIL, said: "The research carried out by the 2,000 scientists already working at Norwich Science Park is world-class and it makes absolute sense to create a facility on this site where the results of such research can be taken through to applications."

Prof Douglas Kell, chief executive of BBSRC, added: "The Norwich Research Park is home to three world-class BBSRC institutes: the John Innes Centre, the Institute of Food Research and The Genome Analysis Centre. This new facility will play a key role in helping our scientists, and others, to translate their excellent science into products to benefit the economy and people of the UK."




See more

You may also like

Research & Development

Reacta Healthcare announces expansion into Asia-Pacific and appoints Professor Gary Wing-Kin Wong to advisory board

Read more
Reacta Healthcare, a leading developer and manufacturer of pharmaceutical-grade oral food challenge (OFC) products for food allergy diagnostics, today announces the appointment of Professor Gary Wing-Kin Wong, internationally recognised paediatric allergy and respiratory disease expert and President-Elect of the World Allergy Organisation (WAO), to its Advisory Board, as the company accelerates new product development and expands its Asia-Pacific (APAC) footprint

Trending Articles

  1. Ecolab Life Sciences opens bioprocessing applications lab in Korea to support downstream process development across Asia New facility serves biopharma manufacturers throughout the region with local access to customer purification studies across Ecolab's Purolite Resin portfolio
  2. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  3. Lancet Oncology Commission launches to examine future of academic cancer clinical trials amid funding and regulatory pressures A global coalition of clinical investigators and patient representatives has launched the Lancet Oncology Commission to address the value and challenges of independent academic cancer clinical trials, amid growing concerns over regulatory complexity, limited public funding and the need for new international collaboration models
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    UK clinical trial reforms come into force in largest regulatory overhaul in 20 years The MHRA and Health Research Authority are implementing the most significant package of clinical trial regulatory reforms in more than two decades, introducing faster assessment routes for lower-risk trials and mandatory registration of trial results
  5. L.B. Bohle will exhibit a wide range of its advanced machinery at Interpack 2026 L.B. Bohle has been a leading exhibitor at interpack, one of Europe’s leading packaging and process expos for many years. For 2026, it will exhibit under its own banner from Booth B41 In Hall 16 of the Düsseldorf Messe expo center

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Research & Development

Reacta Healthcare announces expansion into Asia-Pacific and appoints Professor Gary Wing-Kin Wong to advisory board

Reacta Healthcare, a leading developer and manufacturer of pharmaceutical-grade oral food challenge (OFC) products for food allergy diagnostics, today announces the appointment of Professor Gary Wing-Kin Wong, internationally recognised paediatric allergy and respiratory disease expert and President-Elect of the World Allergy Organisation (WAO), to its Advisory Board, as the company accelerates new product development and expands its Asia-Pacific (APAC) footprint
Manufacturing

AstraZeneca resumes £300m UK investment as drug pricing and tariff landscape shifts

The Cambridge and Macclesfield programmes, paused amid NHS reimbursement disputes, are back on track following the US-UK pharmaceutical deal and a revised NHS rebate rate
Finance

BASF reports Q1 earnings as currency headwinds and Middle East conflict weigh on revenue

The German chemicals giant posted solid volume growth across most segments in the first quarter of 2026, but adverse currency effects eroded sales and pushed EBITDA before special items down
Manufacturing

DINAMIQS secures Swissmedic licence for viral vector GMP manufacturing at Zurich facility

Siegfried-owned DINAMIQS has gained Swissmedic approval to manufacture and release ATMPs, establishing itself as Switzerland’s first fully integrated viral vector CDMO with end-to-end cGMP capabilities.
Manufacturing

VIVEbiotech and Zelluna expand lentiviral vector partnership to advance off-the-shelf TCR-NK therapy for solid tumours

The pair have announced an update to their long-standing manufacturing partnership, advancing lentiviral vector production for Zelluna's lead TCR-NK programme, ZI-MA4-1, targeting the MAGE-A4 tumour antigen, which is planned to enter clinical trials in 2026
Research & Development

BioDuro and CTI Technology partner to push forward preclinical drug development

The duo will combine their manufacturing experience and analytical capabilities to build an integrated platform spanning all the way from drug discovery to IND submission to accelerate the drug development path for clients
Manufacturing

Romaco unveils the KTS 840 at interpack - Powerful tableting technology for triple-layer tablets

Karlsruhe/Germany, 2026-04-28 - At interpack 2026, Romaco Kilian will be presenting the KTS 840 – its new tablet press for triple-layer applications. This robust rotary tablet press was specially designed for use in the nutraceutical and food industries. In addition, Romaco will join with Theegarten-PACTEC to exhibit a high speed line for compressing and packaging bouillon cubes. With the KTP 1X compaction simulator, Romaco will showcase its expertise in research and development
Subscribe now